外科医生改良开窗支架用于钝性创伤性胸主动脉损伤2区腔内修复的早期与中期结果
本研究比较外科医生改良开窗支架(SMFSG)与其他常规腔内方法在钝性创伤性胸主动脉损伤(BTAI)2区腔内修复中的早期与中期结局。两组在近端锚定区、透视时间、手术时间、ICU住院时间和总住院时间上无统计学显著差异(p>0.05);第2组随访期间无TEVAR相关并发症,第1组有4例(28.6%)发生。作者认为TEVAR是BTAI最合适的治疗,SMFSG是左锁骨下动脉腔内血运重建的有效、经济、快速且可用的技术。
要点
- SMFSG组随访期间无TEVAR相关并发症,常规腔内治疗组有4例(28.6%)发生。
- 两组在近端锚定区、透视时间、手术时间、ICU住院时间和住院时间上无统计学显著差异(p>0.05)。
- 作者认为TEVAR是BTAI最合适的治疗,SMFSG是左锁骨下动脉腔内血运重建的有效、经济、快速且可用的技术。
核心结论
- 作者认为TEVAR是当代BTAI最合适的治疗,尤其对多发伤患者可获得成功结局。
- 作者认为可有意覆盖左锁骨下动脉,但SMFSG是左锁骨下动脉腔内血运重建的有效、经济、快速且可用的技术。
研究设计与样本
- 研究比较2015年1月至2020年1月采用常规腔内方法(第1组)与2020年1月至2023年1月采用SMFSG(第2组)行2区腔内修复的BTAI患者。
- 主要终点为技术成功(定义为BTAI完全封闭)和院内死亡,次要终点为随访期间主动脉病变相关并发症、死亡和再干预。
主要发现
- 患者平均年龄42.6±14.3岁,21例(84%)为男性。
- 第1组平均随访46±9个月,第2组平均随访14±6个月(p<0.001)。
- 第2组随访期间无TEVAR相关并发症,第1组有4例(28.6%)发生TEVAR相关并发症。
- 两组在近端锚定区、透视时间、手术时间、ICU住院时间和住院时间上无统计学显著差异(p>0.05)。
临床怎么用
- 作者认为TEVAR是BTAI最合适的治疗,尤其对多发伤患者可获得成功结局。
- 作者认为可有意覆盖左锁骨下动脉,但SMFSG是左锁骨下动脉腔内血运重建的有效、经济、快速且可用的技术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Blunt traumatic thoracic aortic injury (BTAI) is a highly fatal surgical emergency and is treated with endovascular procedures. We aimed to analyze and report the early and midterm outcomes of surgeon-modified fenestrated stent-grafts (SMFSG) compared with other conventional endovascular methods in patients with BTAI repaired with zone 2 endovascular surgery. MATERIALS AND METHODS: Before and after the study was performed, from January 2015 to January 2020 for a period in which conventional endovascular treatments were used and from January 2020 to January 2023 for the second period in which the SMFSG technique was used. A total of 25 patients who underwent zone 2 endovascular repair for BTAI were included. The patients treated with conventional endovascular methods in the first period, chimney thoracic endovascular aortic repair (TEVAR) (n=3 patients); Left subclavian artery (LSA)-covered (intentionally total) (n=12 patients) LSA-covered (LSAC) TEVAR; carotid-subclavian bypass TEVAR (n=2 patients) was defined as group 1, and the group of patients treated with SMFSG in the second period was defined as group 2. The primary endpoints of the study were technical success, defined as complete closure of BTAI, and in-hospital mortality. Secondary outcomes were aortic pathology-related morbidity, mortality, and re-interventions during the follow-up period. RESULTS: The mean age was 42.6±14.3 years, and 21 (84%) of the patients were male. The patients were compared with respect to the proximal landing zone, fluoroscopy time, duration of the procedure, length of intensive care unit stay, and hospital stay, no statistically significant difference was found between the 2 groups (p>0.05). The mean follow-up time of patients in group I was 46±9 months, while in group II, it was 14±6 months (p<0.001). While no TEVAR-related complications were detected in group II throughout follow-up, they occurred in 4 patients (28.6%) in group I. CONCLUSION: TEVAR is the most appropriate treatment for BTAI in the modern era, especially for polytrauma patients with successful outcomes. Intentional coverage of the LSA can be performed, but SMFSG is an effective, economical, rapid, and available technique for endovascular revascularization of the LSA.Clinical ImpactAltough intentional left subclavian artery coverage is preferred routinely in patients with blunt traumatic aortic injury (in Zone 2) which is a highly fatal surgical emergency, surgeon-modified fenestrated stent-grafts is also effective, economical, rapid and available technique.
引用
- Mavioglu L, Iscan HZ, Askin G, et al. Surgeon-Modified Fenestrated Stent-grafts for Zone 2 Endovascular Repair of Blunt Traumatic Thoracic Aortic Injury: Early and Midterm Results. J Endovasc Ther. 2023. PMID: 37728012. doi:10.1177/15266028231199036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。